Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)
Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)
This is a study to evaluate the safety, tolerability, and potential effects of Anatabloc
 dietary supplementation on antithyroid autoantibodies, thyroid structure, and thyroid
 function in subjects with autoimmune thyroiditis.
This is a 5-visit, 12-week, double-blind, randomized, placebo-controlled, parallel-group
 study.
Inclusion Criteria:

 -  adults 18-70 years of age

 -  having positive antibodies against thyroid peroxidase

 -  having sonographic evidence consistent with a diagnosis of Hashimoto's thyroiditis

 Exclusion Criteria:

 -  having evidence of end-stage thyroiditis

 -  being a current smoker or smokeless tobacco user

 -  be taking systemic glucocorticoids, interferon-alpha, anti-CD20 antibody, or
 anti-CTLA-4 antibody

 -  be taking any medication for treatment of autoimmune thyroiditis other than
 L-thyroxine or equivalent